As FGF21 has remarkable pharmacological effects on glucose and lipid metabolism, and potential protective effects on liver stress, our finding will provide useful information on understanding the mechanisms of the transcriptional regulation of FGF21 expression and propose a potential therapeutic strategy for the treatment of obesity and stress associated liver diseases. The gene discussed is FGF21; the disease is obesity disorder.